Cargando…
Nonconserved miR‐608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 pathways by targeting the 3′‐UTRs of RAC2/BCL2L1 and the coding region of PAK4
The aim of this study is to investigate the functions and mechanisms of miR‐608 in prostate cancer (PCa). CISH and qRT‐PCR analysis demonstrated that miR‐608 was low expressed in PCa tissues and cells, which was partly attributed to the methylation of CpG island adjacent to the transcription start s...
Autores principales: | Zhang, Xu, Fang, Jiajie, Chen, Shiming, Wang, Weiyu, Meng, Shuai, Liu, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746107/ https://www.ncbi.nlm.nih.gov/pubmed/31389670 http://dx.doi.org/10.1002/cam4.2455 |
Ejemplares similares
-
Expression and significance of Rac1, Pak1 and Rock1 in gastric carcinoma2
por: Wu, Yong-jun, et al.
Publicado: (2014) -
Effect of PAK Inhibition on Cell Mechanics Depends on Rac1
por: Mierke, Claudia Tanja, et al.
Publicado: (2020) -
A missense variant at the RAC1-PAK1 binding site of RAC1 inactivates downstream signaling in VACTERL association
por: Seyama, Rie, et al.
Publicado: (2023) -
Suppression of RAC1-driven malignant melanoma by Group A PAK inhibitors
por: Araiza-Olivera, Daniela, et al.
Publicado: (2017) -
A Trio-Rac1-PAK1 signaling axis drives invadopodia disassembly
por: Moshfegh, Yasmin, et al.
Publicado: (2014)